Project 3: needs approval from authorities
Working title: “AGEART PLUS”
Therapeutic Area: Gynecology – Hormone Replacement Therapy (HRT)
Application Form: Tablet, coated Tablet, Capsule
Route of Administration: oral
Probability of Realization: high
Daily 8-PN dose (mg): 50mg 8-PN plus 20µg/d norgestrel or 35µg norethisterone acetate or 100µg drospirenone or any other progestin in an equivalent dose
Scientific Basis: Oral combined HRT products have been on the market for a long time. AGEART PLUS, the only product containing a plant derived estrogenic component, would compliment the universe of products already on the market.
Time to Market (best guess): 4-5 years